Informed Momentum Co LLC Sells 21,483 Shares of Lifevantage Corporation (NASDAQ:LFVN)

Key Points

• Informed Momentum Co LLC has reduced its stake in Lifevantage Corporation by 35.7%, trimming its holdings to approximately 38,760 shares valued at $565,000.
• Institutional ownership of Lifevantage now stands at 35.32%, with notable increases from several firms, including Capital Management Corp VA, which grew its position by 137.2% in the first quarter.
• Lifevantage's stock has recently seen an increase of 2.9%, with shares trading at $14.16 as of Wednesday.

Informed Momentum Co LLC decreased its position in Lifevantage Corporation (NASDAQ:LFVN - Free Report) by 35.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 38,760 shares of the company's stock after selling 21,483 shares during the quarter. Informed Momentum Co LLC owned about 0.31% of Lifevantage worth $565,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Core Wealth Partners LLC acquired a new stake in Lifevantage in the 1st quarter worth approximately $480,000. XTX Topco Ltd bought a new stake in shares of Lifevantage during the first quarter valued at approximately $186,000. Capital Management Corp VA increased its position in shares of Lifevantage by 137.2% during the first quarter. Capital Management Corp VA now owns 715,503 shares of the company's stock valued at $10,432,000 after purchasing an additional 413,918 shares during the period. Brown Advisory Inc. bought a new stake in shares of Lifevantage during the first quarter valued at approximately $150,000. Finally, Calamos Advisors LLC bought a new stake in shares of Lifevantage during the first quarter valued at approximately $490,000. Institutional investors own 35.32% of the company's stock.

Lifevantage Stock Down 1.4%

NASDAQ:LFVN traded down $0.19 during trading hours on Friday, reaching $13.49. The company had a trading volume of 80,937 shares, compared to its average volume of 100,539. The stock has a 50-day moving average of $12.99 and a two-hundred day moving average of $14.38. Lifevantage Corporation has a one year low of $7.09 and a one year high of $27.38. The firm has a market capitalization of $169.84 million, a PE ratio of 19.55 and a beta of 0.45.

Insiders Place Their Bets

In other Lifevantage news, CFO Carl Aure sold 2,746 shares of the company's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $13.39, for a total value of $36,768.94. Following the sale, the chief financial officer directly owned 133,303 shares in the company, valued at $1,784,927.17. This represents a 2.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 20.65% of the stock is owned by company insiders.

Lifevantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.